APO RESEARCH · REPORT
Breast Cancer Screening
Breast cancer screening is the medical screening of asymptomatic, apparently healthy women for breast cancer in an attempt to achieve an earlier diagnosis.
Product & engineering
Understand the product.
Breast cancer screening is the medical screening of asymptomatic, apparently healthy women for breast cancer in an attempt to achieve an earlier diagnosis.
A number of screening tests have been employed, including clinical and self-breast exams, mammography, genetic screening, ultrasound, and magnetic resonance imaging.
Selected research
Market Structure
Global Breast Cancer Screening Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
Breast cancer screening is the medical screening of asymptomatic, apparently healthy women for breast cancer in an attempt to achieve an earlier diagnosis.
A number of screening tests have been employed, including clinical and self-breast exams, mammography, genetic screening, ultrasound, and magnetic resonance imaging.
Global Breast Cancer Screening key players include Hologic, GE Healthcare, Siemen Healthineers, etc. Global top three manufacturers hold a share about 65%.
Read the full market overview
North America is the largest market, with a share about 50%, followed by Europe and Asia-Pacific, both have a share about 40 percent.
In terms of product, Mammography Screening is the largest segment, with a share about 70%. And in terms of application, the largest application is Hospital, followed by Clinic.
This report provides an overview of the global Breast Cancer Screening market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Breast Cancer Screening and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Breast Cancer Screening sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Breast Cancer Screening market size, projected growth trends, production technologies, key applications, and end-use industries.
Breast Cancer Screening Segment by Company
Hologic
GE Healthcare
Siemen Healthineers
Philips Healthcare
Canon Medical
Fujifilm
Metaltronica
Sino Medical-Device
IMS Srl
Breast Cancer Screening Segment by Type
Mammography Screening
Breast Magnetic Resonance Imaging (MRI) Screening
Breast Ultrasound Screening
Breast Cancer Screening Segment by Application
Hospital
Clinic
Breast Cancer Screening Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Breast Cancer Screening market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Breast Cancer Screening and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Breast Cancer Screening.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Provides an overview of the Breast Cancer Screening market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Breast Cancer Screening manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Breast Cancer Screening in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Breast Cancer Screening in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- Mammography Screening
- Breast Magnetic Resonance Imaging (MRI) Screening
- Breast Ultrasound Screening
Applications
- Hospital
- Clinic
Companies covered
- Hologic
- GE Healthcare
- Siemen Healthineers
- Philips Healthcare
- Canon Medical
- Fujifilm
- Metaltronica
- Sino Medical-Device
- IMS Srl
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Breast Cancer Screening Market Size, 2021 VS 2025 VS 2032
- 1.3 Global Breast Cancer Screening Market Size Estimates and Forecasts (2021-2032)
- 1.4 Global Breast Cancer Screening Sales Estimates and Forecasts (2021-2032)
- 1.5 Global Breast Cancer Screening Market Average Price (2021-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
2 Global Breast Cancer Screening Market Dynamics
- 2.1 Breast Cancer Screening Industry Trends
- 2.2 Breast Cancer Screening Industry Drivers
- 2.3 Breast Cancer Screening Industry Opportunities and Challenges
- 2.4 Breast Cancer Screening Industry Restraints
3 Breast Cancer Screening Market by Manufacturers
- 3.1 Global Breast Cancer Screening Revenue by Manufacturers (2021-2026)
- 3.2 Global Breast Cancer Screening Sales by Manufacturers (2021-2026)
- 3.3 Global Breast Cancer Screening Average Sales Price by Manufacturers (2021-2026)
- 3.4 Global Breast Cancer Screening Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Breast Cancer Screening Key Manufacturers Manufacturing Sites & Headquarters
- 3.6 Global Breast Cancer Screening Manufacturers, Product Type & Application
- 3.7 Global Breast Cancer Screening Manufacturers Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Breast Cancer Screening Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Breast Cancer Screening Players Market Share by Revenue in 2025
- 3.8.3 2025 Breast Cancer Screening Tier 1, Tier 2, and Tier 3
4 Breast Cancer Screening Market by Type
- 4.1 Breast Cancer Screening Type Introduction
- 4.1.1 Mammography Screening
- 4.1.2 Breast Magnetic Resonance Imaging (MRI) Screening
- 4.1.3 Breast Ultrasound Screening
- 4.2 Global Breast Cancer Screening Sales by Type
- 4.2.1 Global Breast Cancer Screening Sales by Type (2021 VS 2025 VS 2032)
- 4.2.2 Global Breast Cancer Screening Sales by Type (2021-2032)
- 4.2.3 Global Breast Cancer Screening Sales Market Share by Type (2021-2032)
- 4.3 Global Breast Cancer Screening Revenue by Type
- 4.3.1 Global Breast Cancer Screening Revenue by Type (2021 VS 2025 VS 2032)
- 4.3.2 Global Breast Cancer Screening Revenue by Type (2021-2032)
- 4.3.3 Global Breast Cancer Screening Revenue Market Share by Type (2021-2032)
5 Breast Cancer Screening Market by Application
- 5.1 Breast Cancer Screening Application Introduction
- 5.1.1 Hospital
- 5.1.2 Clinic
- 5.2 Global Breast Cancer Screening Sales by Application
- 5.2.1 Global Breast Cancer Screening Sales by Application (2021 VS 2025 VS 2032)
- 5.2.2 Global Breast Cancer Screening Sales by Application (2021-2032)
- 5.2.3 Global Breast Cancer Screening Sales Market Share by Application (2021-2032)
- 5.3 Global Breast Cancer Screening Revenue by Application
- 5.3.1 Global Breast Cancer Screening Revenue by Application (2021 VS 2025 VS 2032)
- 5.3.2 Global Breast Cancer Screening Revenue by Application (2021-2032)
- 5.3.3 Global Breast Cancer Screening Revenue Market Share by Application (2021-2032)
6 Global Breast Cancer Screening Sales by Region
- 6.1 Global Breast Cancer Screening Sales by Region: 2021 VS 2025 VS 2032
- 6.2 Global Breast Cancer Screening Sales by Region (2021-2032)
- 6.2.1 Global Breast Cancer Screening Sales by Region (2021-2026)
- 6.2.2 Global Breast Cancer Screening Sales Forecasted by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Breast Cancer Screening Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Breast Cancer Screening Sales by Country (2021-2032)
- 6.3.3 U.S.
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Breast Cancer Screening Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Breast Cancer Screening Sales by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Netherlands
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Breast Cancer Screening Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Breast Cancer Screening Sales by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 Southeast Asia
- 6.5.7 India
- 6.5.8 Australia
- 6.6 South America, Middle East and Africa
- 6.6.1 South America, Middle East and Africa Breast Cancer Screening Sales Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East and Africa Breast Cancer Screening Sales by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 South Africa
- 6.6.5 Saudi Arabia
- 6.6.6 Turkey
- 6.6.6 Argentina
- 6.6.6 UAE
- 6.6.6 Egypt
- 6.6.6 Chile
7 Global Breast Cancer Screening Revenue by Region
- 7.1 Global Breast Cancer Screening Revenue by Region
- 7.1.1 Global Breast Cancer Screening Revenue by Region: 2021 VS 2025 VS 2032
- 7.1.2 Global Breast Cancer Screening Revenue by Region (2021-2026)
- 7.1.3 Global Breast Cancer Screening Revenue by Region (2027-2032)
- 7.1.4 Global Breast Cancer Screening Revenue Market Share by Region (2021-2032)
- 7.2 North America
- 7.2.1 North America Breast Cancer Screening Revenue (2021-2032)
- 7.2.2 North America Breast Cancer Screening Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.3 Europe
- 7.3.1 Europe Breast Cancer Screening Revenue (2021-2032)
- 7.3.2 Europe Breast Cancer Screening Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.4 Asia-Pacific
- 7.4.1 Asia-Pacific Breast Cancer Screening Revenue (2021-2032)
- 7.4.2 Asia-Pacific Breast Cancer Screening Revenue Share by Country: 2021 VS 2025 VS 2032
- 7.5 South America, Middle East and Africa
- 7.5.1 South America, Middle East and Africa Breast Cancer Screening Revenue (2021-2032)
- 7.5.2 South America, Middle East and Africa Breast Cancer Screening Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
- 8.1 Hologic
- 8.1.1 Hologic Company Information
- 8.1.2 Hologic Business Overview
- 8.1.3 Hologic Breast Cancer Screening Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.1.4 Hologic Breast Cancer Screening Product Portfolio
- 8.1.5 Hologic Recent Developments
- 8.2 GE Healthcare
- 8.2.1 GE Healthcare Company Information
- 8.2.2 GE Healthcare Business Overview
- 8.2.3 GE Healthcare Breast Cancer Screening Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.2.4 GE Healthcare Breast Cancer Screening Product Portfolio
- 8.2.5 GE Healthcare Recent Developments
- 8.3 Siemen Healthineers
- 8.3.1 Siemen Healthineers Company Information
- 8.3.2 Siemen Healthineers Business Overview
- 8.3.3 Siemen Healthineers Breast Cancer Screening Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.3.4 Siemen Healthineers Breast Cancer Screening Product Portfolio
- 8.3.5 Siemen Healthineers Recent Developments
- 8.4 Philips Healthcare
- 8.4.1 Philips Healthcare Company Information
- 8.4.2 Philips Healthcare Business Overview
- 8.4.3 Philips Healthcare Breast Cancer Screening Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.4.4 Philips Healthcare Breast Cancer Screening Product Portfolio
- 8.4.5 Philips Healthcare Recent Developments
- 8.5 Canon Medical
- 8.5.1 Canon Medical Company Information
- 8.5.2 Canon Medical Business Overview
- 8.5.3 Canon Medical Breast Cancer Screening Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.5.4 Canon Medical Breast Cancer Screening Product Portfolio
- 8.5.5 Canon Medical Recent Developments
- 8.6 Fujifilm
- 8.6.1 Fujifilm Company Information
- 8.6.2 Fujifilm Business Overview
- 8.6.3 Fujifilm Breast Cancer Screening Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.6.4 Fujifilm Breast Cancer Screening Product Portfolio
- 8.6.5 Fujifilm Recent Developments
- 8.7 Metaltronica
- 8.7.1 Metaltronica Company Information
- 8.7.2 Metaltronica Business Overview
- 8.7.3 Metaltronica Breast Cancer Screening Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.7.4 Metaltronica Breast Cancer Screening Product Portfolio
- 8.7.5 Metaltronica Recent Developments
- 8.8 Sino Medical-Device
- 8.8.1 Sino Medical-Device Company Information
- 8.8.2 Sino Medical-Device Business Overview
- 8.8.3 Sino Medical-Device Breast Cancer Screening Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.8.4 Sino Medical-Device Breast Cancer Screening Product Portfolio
- 8.8.5 Sino Medical-Device Recent Developments
- 8.9 IMS Srl
- 8.9.1 IMS Srl Company Information
- 8.9.2 IMS Srl Business Overview
- 8.9.3 IMS Srl Breast Cancer Screening Sales, Price, Revenue and Gross Margin (2021-2026)
- 8.9.4 IMS Srl Breast Cancer Screening Product Portfolio
- 8.9.5 IMS Srl Recent Developments
9 Value Chain and Sales Channels Analysis
- 9.1 Breast Cancer Screening Value Chain Analysis
- 9.1.1 Breast Cancer Screening Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Manufacturing Cost Structure
- 9.1.4 Breast Cancer Screening Production Mode & Process
- 9.2 Breast Cancer Screening Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Breast Cancer Screening Distributors
- 9.2.3 Breast Cancer Screening Customers
10 Concluding Insights
11 Appendix
- 11.1 Reasons for Doing This Study
- 11.2 Research Methodology
- 11.3 Research Process
- 11.4 Authors List of This Report
- 11.5 Data Source
- 11.5.1 Secondary Sources
- 11.5.2 Primary Sources
- 11.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst